前收市價 | 0.3500 |
開市 | 0.3500 |
買盤 | 0.1500 |
賣出價 | 0.3000 |
拍板 | 110.00 |
到期日 | 2024-08-16 |
今日波幅 | 0.3500 - 0.3500 |
合同範圍 | 無 |
成交量 | |
未平倉合約 | 2.6k |
HOLX vs. EW: Which Stock Is the Better Value Option?
Investors are optimistic about Edward Lifesciences (EW), led by the strong performance of its SAPIEN 3 Ultra RESILIA platform and strong solvency.
On Monday, U.S. heart valve manufacturer Edwards Lifesciences Corporation (NYSE:EW) faced an EU antitrust complaint from Indian competitor Meril, alleging anti-competitive behavior, particularly concerning patents. This could potentially intensify EU regulators’ scrutiny of Edwards, Reuters reports. Recent regulatory actions in the United States and Europe aim to promote fair competition and maintain drug and product affordability, especially for smaller innovative companies challenging larger i